Bristol Myers Squibb is a biopharmaceutical company developing medicines for serious diseases. It operates within the wider industry that supplies medical treatments to patients.
Its portfolio includes treatments in oncology, cardiovascular care and immunology. Research, clinical trials and medicine manufacturing support its global pharmaceutical operations.
Pharmaceutical businesses turn scientific research into medicines used in healthcare. Clinical evidence, regulatory approvals and manufacturing quality are central to this process, while treatment needs, product access and patent protection influence the commercial life of medicines.
Relacionado con Noticias e información del mercado